285 related articles for article (PubMed ID: 9185754)
21. Transjugular intrahepatic portosystemic shunt for symptomatic refractory hepatic hydrothorax in patients with cirrhosis.
Dhanasekaran R; West JK; Gonzales PC; Subramanian R; Parekh S; Spivey JR; Martin LG; Kim HS
Am J Gastroenterol; 2010 Mar; 105(3):635-41. PubMed ID: 19904245
[TBL] [Abstract][Full Text] [Related]
22. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
23. Transjugular intrahepatic portosystemic shunts in liver transplant recipients.
Kim JJ; Dasika NL; Yu E; Fontana RJ
Liver Int; 2008 Feb; 28(2):240-8. PubMed ID: 18251981
[TBL] [Abstract][Full Text] [Related]
24. [Hydrothorax in absence of ascites: an unusual complication of hepatic cirrhosis with portal hypertension].
Rombolà F; Spinoso A; Ranieri FS; Bertuccio A; Del Giudice AC; Bertuccio SN
Clin Ter; 2005; 156(4):179-81. PubMed ID: 16342519
[TBL] [Abstract][Full Text] [Related]
25. Utility of transjugular intrahepatic portosystemic shunts in liver-transplant recipients.
Choi DX; Jain AB; Orloff MS
J Am Coll Surg; 2009 Apr; 208(4):539-46. PubMed ID: 19476787
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of refractory ascites using a transjugular intrahepatic portosystemic shunt (TIPS). Clinical case].
Zapata R; Fava M
Rev Med Chil; 1999 Oct; 127(10):1229-35. PubMed ID: 10835740
[TBL] [Abstract][Full Text] [Related]
27. Differences in long-term survival after transjugular intrahepatic portosystemic shunt for refractory ascites and variceal bleed.
Membreno F; Baez AL; Pandula R; Walser E; Lau DT
J Gastroenterol Hepatol; 2005 Mar; 20(3):474-81. PubMed ID: 15740494
[TBL] [Abstract][Full Text] [Related]
28. Transjugular intrahepatic portosystemic shunt following liver transplantation: can outcomes be predicted?
El Atrache M; Abouljoud M; Sharma S; Abbass AA; Yoshida A; Kim D; Kazimi M; Moonka D; Brown K
Clin Transplant; 2012; 26(4):657-61. PubMed ID: 22309034
[TBL] [Abstract][Full Text] [Related]
29. Prognostic value of hepatocyte proliferative activity after transjugular intrahepatic portosystemic shunt.
Delhaye M; Le Moine O; Degraef C; Devière J; Galand P
Am J Gastroenterol; 2001 Jun; 96(6):1866-71. PubMed ID: 11419841
[TBL] [Abstract][Full Text] [Related]
30. Portosystemic pressure gradient during transjugular intrahepatic portosystemic shunt with Viatorr stent graft: what is the critical low threshold to avoid medically uncontrolled low pressure gradient related complications?
Chung HH; Razavi MK; Sze DY; Frisoli JK; Kee ST; Dake MD; Hellinger JC; Kang BC
J Gastroenterol Hepatol; 2008 Jan; 23(1):95-101. PubMed ID: 18171347
[TBL] [Abstract][Full Text] [Related]
31. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
32. Urgent transjugular intrahepatic portosystemic shunt for control of acute variceal bleeding.
Bañares R; Casado M; Rodríguez-Láiz JM; Camúñez F; Matilla A; Echenagusía A; Simó G; Piqueras B; Clemente G; Cos E
Am J Gastroenterol; 1998 Jan; 93(1):75-9. PubMed ID: 9448179
[TBL] [Abstract][Full Text] [Related]
33. TIPS for patients with refractory hepatic hydrothorax: what is the take-home message?
Chalasani N; Gitlin N
Am J Gastroenterol; 1997 Nov; 92(11):2129-30. PubMed ID: 9362216
[No Abstract] [Full Text] [Related]
34. Management of refractory hepatic hydrothorax.
Porcel JM
Curr Opin Pulm Med; 2014 Jul; 20(4):352-7. PubMed ID: 24811830
[TBL] [Abstract][Full Text] [Related]
35. Correlation between portal/hepatic vein gradient and response to transjugular intrahepatic portosystemic shunt creation in refractory ascites.
Nair S; Singh R; Yoselewitz M
J Vasc Interv Radiol; 2004 Dec; 15(12):1431-4. PubMed ID: 15590801
[TBL] [Abstract][Full Text] [Related]
36. Transjugular intrahepatic portosystemic shunts in hemodialysis-dependent patients and patients with advanced renal insufficiency: safety, caution, and encephalopathy.
Haskal ZJ; Radhakrishnan J
J Vasc Interv Radiol; 2008 Apr; 19(4):516-20. PubMed ID: 18375295
[TBL] [Abstract][Full Text] [Related]
37. Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results.
Pozler O; Krajina A; Vanicek H; Hulek P; Zizka J; Michl A; Elias P
Hepatogastroenterology; 2003; 50(52):1111-4. PubMed ID: 12845992
[TBL] [Abstract][Full Text] [Related]
38. Management of transjugular intrahepatic portosystemic shunt induced refractory hepatic encephalopathy with the parallel technique: results of a clinical follow-up study.
Maleux G; Heye S; Verslype C; Nevens F
J Vasc Interv Radiol; 2007 Aug; 18(8):986-92; quiz 993. PubMed ID: 17675616
[TBL] [Abstract][Full Text] [Related]
39. Transjugular intrahepatic portosystemic shunts for refractory ascites: assessment of clinical and hormonal response and renal function.
Somberg KA; Lake JR; Tomlanovich SJ; LaBerge JM; Feldstein V; Bass NM
Hepatology; 1995 Mar; 21(3):709-16. PubMed ID: 7875668
[TBL] [Abstract][Full Text] [Related]
40. Distal splenorenal shunt versus transjugular intrahepatic portal systematic shunt for variceal bleeding: a randomized trial.
Henderson JM; Boyer TD; Kutner MH; Galloway JR; Rikkers LF; Jeffers LJ; Abu-Elmagd K; Connor J;
Gastroenterology; 2006 May; 130(6):1643-51. PubMed ID: 16697728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]